<!DOCTYPE html>
<html lang="en">
<head>
<?php $id='1668-1475'; include '../../seo.php';?>
<?php include '../../side-nav.php';?>
<div class="page-content">
<!--section-->
<div class="section mt-0">
<div class="breadcrumbs-wrap">
<div class="container">
<div class="breadcrumbs">
<a href="https://sprintdiagnostics.in/">Home</a>
<a href="https://www.sprintdiagnostics.in/hyderabad/test/">Test</a>
<span>IHC - HepPar 1/ HS A </span>
</div>
</div>
</div>
</div>
<!--//section-->
<!--section-->
<div class="section page-content-first">
<div class="container mt-6">
<div class="row">
<div class="col-md-8 col-lg-8 mt-0 mt-md-0 mb-4">
<h1 class="test-h1">IHC - HepPar 1/ HS A </h1>
<div class="post-text">
<p>HepPar 1/ HS A is an immunohistochemical (IHC) staining test often used in the diagnosis and differentiation of hepatocellular carcinoma (HCC), a common type of liver cancer, from other non-hepatic tumors and metastases. This test is essential as it aids doctors in providing a more precise and targeted treatment plan based on the tumor's origin and type. </p>
<p>HepPar 1, or hepatocyte paraffin 1, is a type of antibody that binds specifically to hepatocytes, the main type of cell found in the liver. HS A, or Hepatocyte Specific Antigen, is an antigen found on the surface of hepatocytes. The presence of these markers in a tumor can suggest that the tumor originated from liver cells. </p>
<p>The HepPar 1/ HS A IHC test involves taking a sample of the tumor tissue, which is then treated with specific antibodies that bind to HepPar 1 and HS A. The bound antibodies are subsequently detected using a colored stain that can be seen under a microscope. The presence of HepPar 1 and HS A on the cells suggests that the tumor is likely a hepatocellular carcinoma. </p>
<div class="table-wrap">
<table class="table table-striped">
	<thead>
		<tr>
			<th scope="col">Test Name</th>
			<td scope="col">IHC - HepPar 1/ HS A </td>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th scope="row">Sample Type</th>
			<td>Tissue Sample </td>
		</tr>
		<tr>
			<th scope="row">Preparations Required</th>
			<td>No specific preparation is required for this test. </td>
		</tr>
		<tr>
			<th scope="row">Report Time</th>
			<td>3 days </td>
		</tr>
		<tr>
			<th scope="row">Price in Hyderabad</th>
			<td> â‚¹ 2000 </td>
		</tr>
	</tbody>
</table>
</div>
<div class="post-text">
<h2 class="test-h2 mt-3">Why is the HepPar 1/ HS A IHC test performed?</h2>
<p>The HepPar 1/ HS A IHC test is often ordered when a doctor needs to confirm the diagnosis of hepatocellular carcinoma or wants to differentiate a liver tumor from other types of tumors or metastases.</p>
<h2 class="test-h2 mt-3">Does fasting require for the HepPar 1/ HS A IHC test?</h2>
<p>No, fasting is not required for the HepPar 1/ HS A IHC test.</p>
<!--section achieved-->
	<?php include "../../include/iconsbox.php" ?>
	<!--//section achieved-->
<h2 class="test-h2 mt-3">How is the HepPar 1/ HS A IHC test performed?</h2>
<p>The test involves taking a tissue sample from the tumor, which is then processed in a lab. The tissue is treated with antibodies specific for HepPar 1 and HS A, and any binding is visualized with a colored stain under a microscope.</p>
<h2 class="test-h2 mt-3">When should one get this test?</h2>
<p>This test is typically ordered when there is suspicion of hepatocellular carcinoma, based on other test results, symptoms, or the individual's medical history.</p>
<h2 class="test-h2 mt-3">What information does the HepPar 1/ HS A IHC test provide?</h2>
<p>The test can provide crucial information about the origin of a tumor. If the tumor cells test positive for HepPar 1 and HS A, it suggests that the tumor likely originated from hepatocytes and might be hepatocellular carcinoma.</p>
<h2 class="test-h2 mt-3">What are the normal values for this test?</h2>
<p>In normal liver tissue, HepPar 1 and HS A would be present. However, in a tumor, their presence or absence can suggest the origin of the tumor. Each individual case is different, and the results should be interpreted in the context of other clinical information.</p>
<h2 class="test-h2 mt-3">What precautions should be taken before and after the test?</h2>
<p>No specific precautions are needed before or after this test. However, as the test involves taking a tissue sample, any instructions regarding wound care should be followed post-procedure.</p>
<h2 class="test-h2 mt-3">What factors can affect the levels of HepPar 1/ HS A?</h2>
<p>Technical factors such as the quality of the tissue sample or the processing of the sample can affect the test results. Also, not all hepatocellular carcinomas will express HepPar 1/ HS A, so a negative result does not definitively rule out hepatocellular carcinoma.</p>
<h2 class="test-h2 mt-3">Which doctor should be consulted in case of abnormal values?</h2>
<p>If the test results are abnormal, it would be best to consult with the doctor who ordered the test, who could be a hepatologist or oncologist.</p>
<h2 class="test-h2 mt-3"> What are the modifiable and non-modifiable factors that can affect the HepPar 1/ HS A levels?</h2>
<p>Non-modifiable factors could include the type and stage of the tumor. Modifiable factors are more related to technical aspects of the test, such as sample collection and processing.</p>

<h2 class="test-h2 mt-3"> How often should the HepPar 1/ HS A IHC test be done?</h2>
<p>The frequency of this test is not routine and is dependent on the need for diagnosis or monitoring of hepatocellular carcinoma or similar liver diseases. Your doctor will guide you based on your specific case and disease progression.</p>
<h2 class="test-h2 mt-3"> Can HepPar 1/ HS A levels vary in different conditions?</h2>
<p>Yes, not all hepatocellular carcinomas express HepPar 1/ HS A. The levels can also be influenced by the stage of the tumor and can vary among different patients.</p>
<h2 class="test-h2 mt-3"> Can this test be used to monitor the progress of hepatocellular carcinoma?</h2>
<p>This test is primarily used for diagnosis and differentiation rather than monitoring. Other tests, such as imaging studies and blood tests, are usually used to monitor the progress of hepatocellular carcinoma.</p>
<h2 class="test-h2 mt-3"> Is this test used in conjunction with other tests?</h2>
<p>Yes, this test is usually one part of a diagnostic workup that can include other tests like blood tests, imaging studies, and possibly other IHC tests, depending on the situation.</p>
<h2 class="test-h2 mt-3"> Is the HepPar 1/ HS A IHC test painful?</h2>
<p>This depends on how the sample is collected. If the sample is obtained through a biopsy, there may be some discomfort or pain associated with the procedure. You will be given local anesthesia to minimize any discomfort.</p>
<p>The HepPar 1/ HS A IHC test plays an essential role in diagnosing and distinguishing hepatocellular carcinoma, helping to determine the most effective course of treatment. It is a specialized test that is ordered when there is a clinical suspicion of hepatocellular carcinoma or when a liver tumor's origin needs to be determined. Despite being a highly technical test, it is crucial in managing liver cancer effectively, providing a tailored approach to each patient's treatment. Always consult with your healthcare provider if you have any concerns or questions about this test.</p>

</div>		
</div>			
</div>
<!--form section-->
<?php include "../../include/bookslot.php" ?>
<!--form section-->
</div>
</div>
<!--//section-->
</div>
</div>
<?php include '../../footer.php';?>
</body>
</html>